Clinical trial
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival
NCT02947087 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 11, 2017
- Completion date
- November 13, 2022
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pancreatitis